Skip to main content
. 2021 Jan 5;10(1):47. doi: 10.3390/antibiotics10010047

Table 1.

Demographics of survey participants responded to quantitative and open-ended questions.

Demographics General Practitioners (GPs)
n (%)
Community Pharmacists (CPs)
n (%)
Total
Responses
Quantitative
Responses
(N = 386)
Qualitative
Responses
(N = 212)
Quantitative
Responses
(N = 613)
Qualitative
Responses
(N = 592)
Sex
Male 195 (51.1%) 112 (50.6%) 272 (44.4%) 268 (45.3%)
Female 186 (48.8%) 109 (49.4%) 341 (55.6%) 324 (54.7%)
Education
B. Med science/B. Pharm 4 (1.0%) 4 (1.8%) 518 (84.6%) 515 (87.0%)
MBBS 305 (79.4%) 150 (67.8%) - -
MD 31(8.0%) 28 (12.6%) - -
Masters 39 (10.1%) 35 (16.8%) 71 (11.6%) 71 (12.0%)
PhD 5 (1.30%) 4 (1.8%) 6 (1.0%) 6 (1.0%)
Years of GP/pharmacy practice
≤5 20 (5.2%) 18 (8.1%) 159 (26.1%) 156 (26.4%)
610 43 (11.1%) 40 (18.0%) 142 (23.3%) 139 (23.5%)
>10 322 (83.6%) 163 (73.7%) 308 (50.6%) 297 (50.2%)
Current GP practice/pharmacy practice location
Metro 234 (60.9%) 97(43.9%) 328 (53.9%) 322 (54.4%)
Regional 74 (19.2%) 58 (26.2%) 146 (24.0%) 140 (23.6%)
Rural 62 (16.1%) 54 (24.4%) 122 (20.1%) 119 (20.1%)
Remote 14 (3.6%) 12 (5.4%) 12 (2.0%) 11 (1.9%)
State of work
NSW (New South Wales) 104 (27.0%) 60 (27.1%) 137 (22.4%) 134 (22.6%)
VIC (Victoria) 105 (27.2%) 45 (20.3%) 105 (17.0%) 101 (17.1%)
QLD (Queensland) 73 (18.9%) 42 (19.0%) 139 (22.7%) 134 (22.6%)
ACT (Australian Capital Territory) 5 (1.2%) 4 (1.8%) 9 (1.5%) 9 (1.5%)
SA (South Australia) 39(10.1%) 22 (9.9%) 95 (15.5%) 94 (15.9%)
WA (Western Australia) 36 (9.3%) 18 (8.1%) 72 (11.8%) 71 (12.0%)
TAS (Tasmania) 18 (4.6%) 15 (6.7%) 47 (7.7%) 41 (6.9%)
NT (Northern Territory) 5 (1.3%) 5 (2.2%) 9 (1.5%) 9 (1.5%)
Medical/Pharmacy training
Outside Australia 124 (32.2%) 70 (31.6%) 61 (10.0%) 48 (8.1%)
Inside Australia 261 (67.7%) 151(68.3%) 552 (90.0%) 544 (91.9%)
Completion of antimicrobial modules
Yes 105 (27.4%) 86 (38.9%) 115 (18.8%) 112 (18.9%)
No 200 (52.2%) 103 (46.6%) 280 (45.8%) 270 (45.6%)
Not aware 78 (20.3%) 32 (14.4%) 216 (35.4%) 209 (35.3%)